163 related articles for article (PubMed ID: 7931479)
1. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
2. A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Vici P; Colucci G; Giotta F; Sergi D; Filippelli G; Perri P; Botti C; Vizza E; Carpino A; Pizzuti L; Latorre A; Giannarelli D; Lopez M; Di Lauro L
J Exp Clin Cancer Res; 2011 Apr; 30(1):39. PubMed ID: 21481280
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of vinorelbine by oral route (in a hard gelatine capsule) for metastatic breast cancer patients. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.
Queisser W; Doss A; Wander HE; Bremer K; Becher R; Rieche K; Delgado FM; Edler L
Onkologie; 1991 Feb; 14(1):35-9. PubMed ID: 1647510
[TBL] [Abstract][Full Text] [Related]
4. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
Tannock IF; Boyd NF; DeBoer G; Erlichman C; Fine S; Larocque G; Mayers C; Perrault D; Sutherland H
J Clin Oncol; 1988 Sep; 6(9):1377-87. PubMed ID: 2458438
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone (M) and vinblastine (V) in the treatment of advanced breast cancer.
Cruciani G; Tienghi A; Fiorentini G; Rosti G; Turci D; Salerno V; Leoni M; Marangolo M
Tumori; 1990 Apr; 76(2):196-8. PubMed ID: 2184548
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin: an active drug in metastatic breast cancer.
Martín M; Díaz-Rubio E; Casado A; Santabárbara P; López Vega JM; Adrover E; Lenaz L
J Clin Oncol; 1992 Mar; 10(3):433-7. PubMed ID: 1740682
[TBL] [Abstract][Full Text] [Related]
8. Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.
Talbot DC; Smith IE; Mansi JL; Judson I; Calvert AH; Ashley SE
J Clin Oncol; 1991 Dec; 9(12):2141-7. PubMed ID: 1960556
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil, epirubicin and cyclophosphamide (FEC combination) in advanced breast cancer.
Zamagni C; Martoni A; Ercolino L; Baroni M; Tanneberger S; Pannuti F
J Chemother; 1991 Apr; 3(2):126-9. PubMed ID: 1875232
[TBL] [Abstract][Full Text] [Related]
10. A review of the antitumour activity of vinorelbine in breast cancer.
Marty M; Extra JM; Dieras V; Giacchetti S; Ohana S; Espié M
Drugs; 1992; 44 Suppl 4():29-35; discussion 66-9. PubMed ID: 1283848
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology Group.
Roth BJ; Sledge GW; Williams SD; Meyer SC; Ansari R; Fisher WB
Cancer; 1991 Jul; 68(2):248-52. PubMed ID: 2070321
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer.
Ransom DT; Neuberg D; Loprinzi CL; Tormey DC; Blum RH; Harris JE; Asbury RF; Falkson G
Am J Clin Oncol; 1991 Feb; 14(1):45-8. PubMed ID: 1898999
[TBL] [Abstract][Full Text] [Related]
13. [Study of vinorelbine (V) combined with hexamethylmelamine (H) (combination V-H) in adenocarcinoma of the ovary: results a phase I-IIA trial, NHO-88, of ARTAC "ovarian" group].
Pinon G; Pinel MC; Goudier MJ; Coiffier B; Filippi MH; Goupil A; Roullet B; Facchini T; Mignot L; Tresca P
Bull Cancer; 1991; 78(12):1119-31. PubMed ID: 1786425
[TBL] [Abstract][Full Text] [Related]
14. Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer.
Beex LV; Hermus AR; Pieters GF; van Hoesel QG; Nooy MA; Mignolet F
Eur J Cancer; 1992; 28(2-3):686-90. PubMed ID: 1591094
[TBL] [Abstract][Full Text] [Related]
15. High-dose epirubicin in combination with cyclophosphamide (HD-EC) in advanced breast cancer: final results of a dose finding study and phase II trial.
Marschner N; Nagel GA; Beyer JH; Adler M; Ammon A
Onkologie; 1990 Aug; 13(4):272-8. PubMed ID: 2234780
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Adelson MD; Hanjani P
Invest New Drugs; 1990 Nov; 8(4):377-9. PubMed ID: 2084071
[TBL] [Abstract][Full Text] [Related]
17. Association of bolus tetrahydropyranyl adriamycin and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancer.
Chevallier B; Fumoleau P; Kerbrat P; Monnier A; Roche H; Goudie MJ; Herait P
Am J Clin Oncol; 1990; 13 Suppl 1():S40-3. PubMed ID: 2291456
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer.
Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
Am J Clin Oncol; 1991 Apr; 14(2):115-9. PubMed ID: 1851385
[TBL] [Abstract][Full Text] [Related]
19. Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial.
Gasparini G; Dal Fior S; Panizzoni GA; Favretto S; Pozza F
Am J Clin Oncol; 1991 Feb; 14(1):38-44. PubMed ID: 1987737
[TBL] [Abstract][Full Text] [Related]
20. Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer.
Cebon JS; Bishop JF; Harvey V; Mason B; Jeal PN
Br J Cancer; 1990 Jan; 61(1):133-6. PubMed ID: 2297484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
